Enterome, Nestlé Health Science Launch Microbiome Diagnostics Partners to Develop New IBD Treatments

Enterome, Nestlé Health Science Launch Microbiome Diagnostics Partners to Develop New IBD Treatments
France’s Enterome and Switzerland’s Nestlé Health Science have jointly established Microbiome Diagnostics Partners (MDP), a new company created to discover and develop innovative diagnostics for inflammatory bowel disease (IBD), liver disease and other illnesses. The gut microbiome, or the community of microorganisms that live in human guts, plays a critical role in building up a person’s natural immunity and maintaining

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *